Glen Wheeler

Summary

Publications

  1. ncbi request reprint Gabapentin. Pfizer
    Glen Wheeler
    Curr Opin Investig Drugs 3:470-7. 2002
  2. ncbi request reprint RG-1068 RepliGen
    Glen Wheeler
    Curr Opin Investig Drugs 4:66-71. 2003
  3. ncbi request reprint Ruboxistaurin (Eli Lilly)
    Glen D Wheeler
    102 711 West 17th Avenue, Vancouver, BC V5Z 1V1, Canada
    IDrugs 6:159-63. 2003

Detail Information

Publications3

  1. ncbi request reprint Gabapentin. Pfizer
    Glen Wheeler
    Curr Opin Investig Drugs 3:470-7. 2002
    ..In September 2001, Morgan Stanley predicted sales of US $1871 million in 2002 falling to US $413 million in 2006...
  2. ncbi request reprint RG-1068 RepliGen
    Glen Wheeler
    Curr Opin Investig Drugs 4:66-71. 2003
    ..RG-1068 received Fast Track designation for the treatment of pediatric autism in September 2001, and in February 2002, it entered phase III clinical trials...
  3. ncbi request reprint Ruboxistaurin (Eli Lilly)
    Glen D Wheeler
    102 711 West 17th Avenue, Vancouver, BC V5Z 1V1, Canada
    IDrugs 6:159-63. 2003
    ....